Accuray Incorporated (ARAY) États Financiers et Données Historiques

Accuray Incorporated (ARAY) — Prix $0.23 HealthcareMedical - Devices — NASDAQ

Derniers résultats publiés:

États financiers détaillés de Accuray Incorporated (ARAY): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

Accuray Incorporated a enregistré un chiffre d'affaires de $401.9M sur le dernier exercice, avec un CAGR sur 5 ans de 0.3%.

Marges des 12 derniers mois: marge brute 27.7%, marge opérationnelle -6.6%, marge nette -12.2%.

Au prix actuel de $0.23, ARAY affiche des résultats négatifs (PER non significatif) et un ROE de -99.04%. La capitalisation boursière s'établit à $28M.

Compte de Résultat (10 ans)

Année2017201820192020202120222023202420252026
Revenus$383.4M$404.9M$418.8M$382.9M$396.3M$429.9M$447.6M$446.6M$458.5M$401.9M
Coût des Ventes$242.1M$243.2M$256.1M$233.2M$236.8M$270.0M$293.6M$303.6M$311.5M$290.5M
Marge Brute$141.3M$161.7M$162.7M$149.7M$159.5M$160.0M$154.0M$142.9M$147.0M$111.5M
R&D$49.9M$57.3M$56.5M$49.8M$52.7M$57.8M$57.1M$49.7M$47.9M$37.8M
Frais Généraux$101.2M$108.2M$105.6M$87.4M$84.5M$94.1M$94.4M$92.7M$91.2M$84.0M
Charges Opérationnelles$151.2M$165.5M$162.1M$137.2M$137.3M$151.8M$151.6M$142.4M$139.1M$137.9M
Résultat Opérationnel-$9.8M-$3.8M-$9.9M$12.5M$22.2M$8.1M$2.4M$504000$7.8M-$26.4M
EBITDA$6.8M$1.7M$11.1M$31.3M$18.7M$11.6M$8.4M$5.7M$20.2M-$14.3M
Charges d'Intérêt$17.3M$15.0M$15.1M$18.1M$16.9M$8.1M$10.6M$11.6M$13.0M$35.3M
Résultat Avant Impôts-$28.5M-$23.0M-$14.3M$5.7M-$4.6M-$2.0M-$6.8M-$11.8M$1.1M-$47.2M
Impôts$1.0M$878000$2.1M$1.9M$1.8M$3.3M$2.5M$3.7M$2.7M$1.9M
Résultat Net-$29.6M-$23.9M-$16.4M$3.8M-$6.3M-$5.3M-$9.3M-$15.5M-$1.6M-$49.2M
BPA$-0.36$-0.28$-0.19$0.04$-0.07$-0.06$-0.10$-0.16$-0.02$-0.40
BPA Dilué$-0.36$-0.28$-0.19$0.04$-0.07$-0.06$-0.10$-0.16$-0.02$-0.40
Actions en Circulation (Diluées)$82.5M$84.9M$87.5M$90.6M$92.0M$92.1M$94.9M$98.3M$102.8M$122.6M

Compte de Résultat (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Revenus$93.9M$102.2M$104.8M$100.9M
Marge Brute$26.5M$24.1M$25.3M$35.5M
Résultat Opérationnel-$11.3M-$5.5M-$2.5M-$7.1M
EBITDA-$10.3M-$3.3M-$813000$71000
Résultat Net-$21.7M-$13.8M-$11.8M-$1.9M
BPA$-0.18$-0.11$-0.09$-0.02
BPA Dilué$-0.18$-0.11$-0.09$-0.02

Bilan (10 ans)

Année2017201820192020202120222023202420252026
Trésorerie$72.1M$83.1M$76.8M$107.6M$116.4M$88.7M$89.4M$68.6M$57.4M$41.2M
Placements à Court Terme$23.9M000000000
Créances$72.8M$66.0M$111.9M$90.6M$85.4M$101.5M$87.3M$98.9M$97.9M$67.4M
Stocks$105.1M$108.5M$120.8M$134.4M$125.9M$142.3M$145.2M$138.3M$141.0M$147.1M
Actifs Courants$309.0M$284.2M$344.1M$357.5M$352.8M$350.9M$338.0M$323.2M$317.5M$287.5M
Immobilisations Corporelles$23.1M$23.7M$17.1M$44.0M$34.9M$29.5M$46.8M$58.5M$61.8M$54.8M
Goodwill$57.8M$57.9M$57.8M$57.7M$58.0M$57.8M$57.7M$57.7M$57.8M$57.9M
Actifs Incorporels$964000$821000$679000$663000$435000$250000$210000$59000$150000
Actifs Totaux$406.5M$378.7M$438.2M$490.9M$480.1M$472.8M$479.2M$468.6M$470.2M$443.7M
Dettes Fournisseurs$17.5M$19.7M$29.6M$23.1M$19.5M$31.3M$33.7M$50.0M$34.0M$40.6M
Dette à Court Terme$113.0M000$3.8M$8.6M$5.7M$7.8M$12.7M$9.7M
Passifs Courants$284.5M$169.4M$192.2M$182.3M$192.4M$208.9M$198.6M$195.3M$192.6M$191.4M
Dette à Long Terme$51.5M$131.1M$159.8M$189.3M$170.0M$171.9M$171.6M$164.4M$123.8M$146.4M
Passifs Totaux$359.9M$330.1M$388.3M$427.3M$411.3M$419.7M$425.6M$423.5M$389.1M$402.0M
Réserves-$450.4M-$474.3M-$485.5M-$481.7M-$488.0M-$492.5M-$502.1M-$517.7M-$519.3M-$568.5M
Capitaux Propres$46.5M$48.6M$49.9M$63.6M$68.8M$53.2M$53.7M$45.1M$81.2M$41.7M
Dette Totale$164.6M$131.1M$159.8M$221.7M$199.4M$199.5M$205.0M$210.7M$176.4M$183.9M
Dette Nette$68.6M$48.0M$83.0M$114.1M$83.0M$110.8M$115.6M$142.2M$119.0M$142.6M
Fonds de Roulement$24.5M$114.7M$151.9M$175.2M$160.4M$142.0M$139.4M$128.0M$124.9M$96.1M

Bilan (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Trésorerie$63.9M$41.3M$38.1M$40.6M
Actifs Totaux$456.8M$448.0M$447.6M$443.7M
Passifs Totaux$394.9M$394.6M$405.9M$402.0M
Capitaux Propres$61.9M$53.4M$41.7M$41.7M
Dette Totale$179.1M$204.4M$182.4M$183.9M

Tableau de Flux (10 ans)

Année2017201820192020202120222023202420252026
Résultat Net-$29.6M-$23.9M-$16.4M$3.8M-$6.3M-$5.3M-$9.3M-$15.5M-$1.6M-$49.2M
Amortissements$18.0M$9.7M$10.5M$7.5M$6.4M$5.5M$4.5M$5.9M$6.2M$7.9M
Stock-based Compensation$13.6M$12.3M$10.6M$8.2M$9.3M$10.6M$10.1M$9.5M$10.2M$6.5M
Variation du BFR-$12.5M$10.0M-$46.7M-$21.9M$7.8M-$22.6M$4.6M-$21.9M-$18.2M$11.9M
Cash Flow Opérationnel-$380000$18.3M-$29.6M-$1.5M$38.5M-$2.4M$15.5M-$11.9M$2.9M-$7.0M
CapEx-$5.4M-$6.6M-$4.3M-$3.7M-$2.3M-$4.7M-$12.7M-$3.6M-$8.5M-$5.9M
Acquisitions$333000$33300000-$7900000000
Rachat d'Actions-$1.4M-$29300000-$14.1M00000
Dividendes Payés0000000000
Free Cash Flow-$5.7M$11.7M-$34.0M-$5.2M$36.2M-$7.1M$2.9M-$15.5M-$5.7M-$12.8M

Tableau de Flux (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Cash Flow Opérationnel$12.2M-$16.0M-$5.6M$2.4M
CapEx-$3.8M-$1.1M-$1.5M-$461000
Free Cash Flow$8.4M-$17.1M-$7.1M$2.0M
Dividendes Payés0000
Stock-based Compensation$2.5M$882000$1.4M$1.7M

Croissance et Marges (10 ans)

Année2017201820192020202120222023202420252026
Croissance Revenus (annuelle)+5.6%+3.4%-8.6%+3.5%+8.5%+4.1%-0.2%+2.7%-12.3%
Croissance Résultat Net (annuelle)+19.2%+31.3%+123.3%-264.9%+15.3%-73.6%-67.5%+89.8%-2992.0%
Croissance BPA (annuelle)+22.2%+32.1%+122.4%-261.0%+15.3%-68.3%-63.6%+90.3%-2480.6%
Variation Actions (annuelle)+2.9%+3.0%+3.6%+1.6%+0.1%+3.0%+3.6%+4.6%+19.3%
Croissance FCF (annuelle)+304.1%-389.6%+84.7%+796.4%-119.7%+140.2%-642.5%+63.5%-126.8%
Marge Brute36.9%39.9%38.8%39.1%40.3%37.2%34.4%32.0%32.1%27.7%
Marge Opérationnelle-2.6%-0.9%-2.4%3.3%5.6%1.9%0.5%0.1%1.7%-6.6%
Marge EBITDA1.8%0.4%2.6%8.2%4.7%2.7%1.9%1.3%4.4%-3.6%
Marge Nette-7.7%-5.9%-3.9%1.0%-1.6%-1.2%-2.1%-3.5%-0.3%-12.2%
Marge FCF-1.5%2.9%-8.1%-1.4%9.1%-1.7%0.6%-3.5%-1.2%-3.2%
Taux d'Imposition Effectif-3.6%-3.8%-14.5%32.7%-38.4%-167.1%-36.7%-31.5%240.3%-4.1%

Données par Action (10 ans)

Année2017201820192020202120222023202420252026
FCF par Action$-0.07$0.14$-0.39$-0.06$0.39$-0.08$0.03$-0.16$-0.06$-0.10
Dividende par Action$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)$82.5M$84.9M$87.5M$89.9M$92.0M$92.1M$94.9M$98.3M$102.8M$122.6M

Quoi regarder en Santé / Pharma

Le pipeline R&D est l'actif invisible. Brevets qui expirent = revenus qui s'évaporent. Regardez innovation et cash flow.

Rentabilité

Rentabilité des capitaux propres-99.04%
Rentabilité du capital investi-10.09%
Rentabilité des actifs-11.09%
Marge brute27.73%
Marge opérationnelle-6.58%
Marge nette-12.24%

Santé financière

Dette / Capitaux propres4.41
Ratio de liquidité1.50

Ratios Clés (10 ans)

Année2017201820192020202120222023202420252026
PER-13.19-14.64-20.5847.65-65.89-33.73-39.57-11.00-88.39-0.64
P/B8.427.166.862.876.043.396.843.841.730.76
P/V1.020.860.820.481.050.420.820.390.310.08
Marge Brute36.9%39.9%38.8%39.1%40.3%37.2%34.4%32.0%32.1%27.7%
Marge Opérationnelle-2.6%-0.9%-2.4%3.3%5.6%1.9%0.5%0.1%1.7%-6.6%
Marge Nette-7.7%-5.9%-3.9%1.0%-1.6%-1.2%-2.1%-3.5%-0.3%-12.2%

Entreprises liées: ANIK · AVR · LNSR · MIST · MXCT · OWLT · PROF

Explorer le secteur: Healthcare · Medical - Devices

Plus de sections de ARAY: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions